This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Sonedenoson

Pfizer Inc.

Drug Names(s): MRE0094, MRE-0094

Description: Sonedenoson is an adenosine A2A receptor agonist that regulates the response of inflammatory cells and mediators and enhances the tissue proliferation phase of wound healing.

Deal Structure: In October 2010, Pfizer and King Pharmaceuticals announced that they have entered into a definitive merger agreement.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug